Form 4: Dolby Laboratories CEO Kevin Yeaman Exercises Options and Sells Shares Under Pre-Arranged Plan

Dolby Laboratories President and CEO Kevin Yeaman executed a pre-planned transaction on June 24, 2025, exercising 25,000 employee stock options and simultaneously selling the same number of Class A Common Stock shares.

Summary

• Kevin J. Yeaman, President and CEO, and a Director of Dolby Laboratories, Inc. (DLB), engaged in a transaction on June 24, 2025.
• The transaction involved the exercise of 25,000 employee stock options at an exercise price of $45.5 per share.
• Concurrently, 25,000 shares of Class A Common Stock were sold at a weighted average price of $74.0212 per share, with individual sales ranging from $73.34 to $74.33.
• The transaction was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following these transactions, Mr. Yeaman's indirect beneficial ownership through the Kevin and Rachel Yeaman Family Trust decreased to 114,725 shares of Class A Common Stock.
• Additionally, Mr. Yeaman directly holds 127,735 shares of Class A common stock underlying restricted stock units and indirectly holds 2.5592 shares through a son.

Sentiment

Score: 6

Explanation: The transaction is a routine insider liquidity event, pre-planned under a 10b5-1 plan, which mitigates negative interpretations of an insider sale. The exercise of options at a lower price and sale at a higher price is a positive for the executive, but the reduction in beneficial ownership through the trust is a slight negative for some investors. Overall, it's a common and expected occurrence for executives.

Positives

• The exercise of employee stock options by a key executive indicates a realization of value from long-term incentives.
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting it was pre-scheduled and not based on immediate, non-public information.
• The sale price of $74.0212 per share is significantly higher than the exercise price of $45.5, indicating a profitable transaction for the executive.

Negatives

• The sale of 25,000 shares by the President and CEO reduces his indirect beneficial ownership through the family trust, which could be perceived by some investors as a reduction in insider alignment, although it's a pre-planned liquidity event.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transactions involved shares held indirectly by the Kevin and Rachel Yeaman Family Trust, which is a related party to the reporting person.
• Shares are also held indirectly by a son, another related party.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even if pre-planned, could be viewed as a slight reduction in insider alignment, though the 10b5-1 plan mitigates this concern. It provides transparency regarding executive compensation and liquidity events.

Key Dates

Recommendation

Keywords

Dolby Laboratories, DLB, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Kevin Yeaman, Rule 10b5-1, Executive Compensation, Beneficial Ownership